Part I
What is a diagnosis
1. Chasing My Cure: Lessons learned from my rare illness
2. A Pragmatic Approach to Diagnostic Categorization
3. How diagnoses are assigned
4. Toward Molecular Diagnoses for Autoimmune Rheumatic Diseases
Part II
Purposes of diagnosis
5. Diagnostic Uncertainty in Drug Development
6. Confronting the Inevitability of Diagnostic Uncertainty Across Multiple Legal Domains
7. The FDA and the Drug Development Process
Part III
Assigning diagnoses
8. Diagnosis of Systemic Lupus Erythematosus in the Age of Precision Medicine
9. The Impact of Antinuclear Antibody Testing on the Naming and Misnaming of Disease
10. In the Box or Out of the Box
11. Ever Evolving Disease Classification Criteria for Clinical Trials and Studies: The Case of Systemic Lupus Erythematosus
12. Prognosis: A framework for clinical practice when patients have symptoms with no diagnosis
13. When the Illness Has No Name: Focus on Clinical Trials in Systemic Lupus Erythematosus
14. The Epidemiology of Systemic Lupus Erythematosus
Part IV
Uncertainty
15. Managing and tolerating diagnostic uncertainty
16. Is there a textbook for non-textbook patients?
17. The Changing Role Of Uncertainty In Physician-Patient Relationships
18. Syndromes in Search of a Name: Disorders of Consciousness, Neuroethics & Nosological Humility
19. Reflections on the Conference by a Physician-Patient
20. Clinical Ambiguity in the Intelligent Machine Era (Treats Breaks and Discharges)
21. Shame, Name, Give Up the Game? Three Approaches to Uncertainty.